Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Itraconazole on BIIB074 PK in Healthy Subjects
NCT02698267Phase 1Completed
- Sponsor
- Biogen
- Start
- Feb 2016
- Primary completion
- Apr 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of vixotrigine in neuropathic pain, sponsored by Biogen. Primary endpoints: Maximum observed concentration of BIIB074 and Area under the concentration-time curve from time zero to infinity of BIIB074. Started Feb 2016; status: completed.
02
Drugs
vixotrigine
03
Conditions
neuropathic pain
Beyond the preview
Go deeper on NCT02698267.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02698267.